Karnataka
News Category
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investigational therapy...
July 23, 2026Read the full article →
Formycon and OneSource Specialty Pharma Forge Strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma have announced a strategic partnership to manufacture biosimilars, leveraging OneSource's integrated capabi...
July 14, 2026Read the full article →
Lantern Pharma Launches ZetaOmics, an AI-Powered Computational Biology Platform
Lantern Pharma announced the launch of ZetaOmics, an AI-driven computational biology module that automates multi-omic analysis, expanding its commerci...
July 8, 2026Read the full article →